1
Weng Tao, David H Rein, Brenda J Dean, Paul F Stabila, Moses B I Goddard: ARPE-19 as a platform cell line for encapsulated cell-based delivery. Neurotech, Ivor R Elrifi Esq, Christina V Karnakis Esq, Mintz Levin Cohn Ferris Glovsky and Popeo PC, March 26, 2002: US06361771 (32 worldwide citation)

ARPE-19 cells were evaluated as a platform cell line for encapsulated and un-encapsulated cell-based delivery technology. ARPE-19 cells were found to be hardy (the cell line is viable under stringent conditions, such as in central nervous system or intra-ocular environment); can be genetically modif ...


2
John F Mills, Edward J Doherty, Tyrone F Hazlett, Keith E Dionne, Nicholas F Warner, Brian M Cain, David H Rein: Method and apparatus for sealing implantable, membrane encapsulation devices containing living cells. Brown University Research Foundation, Leon R Yankwich, Ivor R Elrifi, August 3, 1999: US05932460 (27 worldwide citation)

A sealed, implantable, encapsulation device (20) for diffusing a biologically active product or function to an individual which includes a substantially non-porous fitting (32) including an inner surface (33) defining an access port (34). A permselective, porous, membrane (21), having an interior su ...


3
John F Mills, Edward J Doherty, Tyrone F Hazlett, Keith E Dionne, Nicholas F Warner, Brian M Cain, David H Rein: Method and apparatus for sealing implantable membrane encapsulation devices. Brown University Research Foundation, Ivor E Elrifi, John Prince, Mintz Levin Cohn Ferris Glovsky and Popeo P C, September 26, 2000: US06123700 (23 worldwide citation)

A sealed, implantable, encapsulation device (20) for diffusing a biologically active product or function to an individual which includes a substantially non-porous fitting (32) including an inner surface (33) defining an access port (34). A permselective, porous, membrane (21), having an interior su ...


4
John F Mills, Edward J Doherty, Tyrone F Hazlett, Keith E Dionne, Nicholas F Warner, Brian M Cain, David H Rein: Method and apparatus for sealing implantable membrane encapsulation devices. Brown University Research Foundation, Ivor R Elrifi, Leon R Yankwich, August 5, 1997: US05653688 (16 worldwide citation)

A sealed, implantable, encapsulation device (20) for diffusing a biologically active product or function to an individual which includes a substantially non-porous fitting (32) including an inner surface (33) defining an access port (34). A permselective, porous, membrane (21), having an interior su ...


5
Weng Tao, David H Rein, Brenda J Dean, Paul F Stabila, Moses B I Goddard: ARPE-19 as a platform cell line for encapsulated cell-based delivery. Neurotech, Mintz Levin Cohn Ferris Glovsky and Popeo P C, Ivor R Elrifi, Christina K Stock, October 3, 2006: US07115257 (15 worldwide citation)

ARPE-19 cells were evaluated as a platform cell line for encapsulated and unencapsulated cell-based delivery technology. ARPE-19 cells were found to be hardy (the cell line is viable under stringent conditions, such as in central nervous system or intra-ocular environment); can be genetically modifi ...


6
John F Mills, Edward J Doherty, Tyrone F Hazlett, Keith E Dionne, Nicholas F Warner, Brian M Cain, David H Rein: Method and apparatus for sealing implantable, membrane encapsulation. Brown University Research Foundation, Ivor R Elrifi, Leon R Yankwich, Gregory J Cohan, August 5, 1997: US05653687 (14 worldwide citation)

A sealed, implantable, encapsulation device (20) for diffusing a biologically active product or function to an individual which includes a substantially non-porous fitting (32) including an inner surface (33) defining an access port (34). A permselective, porous, membrane (21), having an interior su ...


7
John F Mills, Edward J Doherty, Tyrone F Hazlett, Keith E Dionne, Nicholas F Warner, Brian M Cain, David H Rein: Method and apparatus for sealing implantable, membrane encapsulation devices. Brown University Research Foundation, Leon R Yankwich, Ivor R Elrifi, February 3, 1998: US05713887 (10 worldwide citation)

A sealed, implantable, encapsulation device (20) for diffusing a biologically active product or function to an individual which includes a substantially non-porous fitting (32) including an inner surface (33) defining an access port (34). A permselective, porous, membrane (21), having an interior su ...


8
John F Mills, Edward J Doherty, Tyrone F Hazlett, Keith E Dionne, Nicholas F Warner, Brian M Cain, David H Rein: Method and apparatus for sealing implantable, membrane encapsulation devices. Brown University Research Foundation, Leon R Yankwich, Ivor R Elrifi, April 14, 1998: US05738673 (10 worldwide citation)

A sealed, implantable, encapsulation device (20) for diffusing a biologically active product or function to an individual which includes a substantially non-porous fitting (32) including an inner surface (33) defining an access port (34). A permselective, porous, membrane (21), having an interior su ...


9
Weng Tao, David H Rein, Brenda J Dean, Paul F Stabila, Moses BI Goddard: ARPE-19 as platform cell line for encapsulated cell-based delivery. Mintz Levin Cohn Ferris Glovsky, And Popeo PC, March 29, 2007: US20070071734-A1

ARPE-19 cells were evaluated as a platform cell line for encapsulated and unencapsulated cell-based delivery technology. ARPE-19 cells were found to be hardy (the cell line is viable under stringent conditions, such as in central nervous system or intra-ocular environment); can be genetically modifi ...


10
Weng Tao, David H Rein, Brenda J Dean, Paul F Stabila, Moses BI Goddard: ARPE-19 as a Platform Cell Line for Encapsulated Cell-Based Delivery. Neurotech Usa, Mintz Levin Cohn Ferris Glovsky And Popeo PC, October 29, 2009: US20090269389-A1

ARPE-19 cells were evaluated as a platform cell line for encapsulated and unencapsulated cell-based delivery technology. ARPE-19 cells were found to be hardy (the cell line is viable under stringent conditions, such as in central nervous system or intra-ocular environment); can be genetically modifi ...